HPV vaccination in women aged 24-45 years.
Schenk
Stefanie
S
Halbekath
Jutta
J
D000328:Adult; D000367:Age Factors; D003627:Data Interpretation, Statistical; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008875:Middle Aged; D053918:Papillomavirus Vaccines / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014611:Vaccination / Q000592:standards; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control / Q000821:virology
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines